6 completed, 1 recruiting, 1 terminated. 4 Phase 1, 2 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Not applicable | 2 | Completed 2 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Cefpodoxime: new trials by email Literature Review of Cefpodoxime trials Research Report on Cefpodoxime
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy | Phase 2 | Recruiting | Massachusetts General Hospital | 300 | 2025-05-05 | 2026-09-04 |
| Comparing Oral Versus Parenteral Antimicrobial Therapy Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid, Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem - Endovascular Infection, Bone and Joint Infection | Phase 4 | Terminated | West Virginia University | 94 | 2023-08-04 | 2025-08-26 |
| Healthy Patients & Effect of Antibiotics Levofloxacin, Azithromycin, Cefpodoxime - Microbiota, Anti-bacterial Agents | Not applicable | Completed | Washington University School of Medicine | 20 | 2017-01-01 | 2022-11-10 |
| A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors Bevacizumab, Temozolomide, Vincristine - Solid Tumor | Phase 1 | Completed | Children's Hospital Medical Center, Cincinnati | 13 | 2008-10-01 | 2021-02-10 |
| Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma Irinotecan and Bortezomib - Neuroblastoma | Phase 1 | Completed | University of Michigan Rogel Cancer Center | 18 | 2008-04-01 | 2017-07-06 |
| Cefpodoxime vs Ciprofloxacin for Acute Cystitis Cefpodoxime, Ciprofloxacin - Urinary Tract Infection | Not applicable | Completed | University of Washington | 300 | 2005-06-01 | 2014-06-10 |
| Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors Irinotecan, Cefpodoxime - Neoplasm, Diarrhea | Phase 1 | Completed | St. Jude Children's Research Hospital | 20 | 2003-09-01 | 2017-04-26 |
| Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors Irinotecan, ZD1839, Vincristine, Cefixime, Cefpodoxime. - Solid Tumors | Phase 1 | Completed | St. Jude Children's Research Hospital | 34 | 2003-05-01 | 2017-04-26 |
Anaphylaxis (1) · Diarrhea (1) · Drug Hypersensitivity (1) · Hypersensitivity (1) · Neoplasms (1) · Neuroblastoma (1) · Soft Tissue Infections (1) · Urinary Tract Infections (1)
St. Jude Children's Research Hospital (2) · Children's Hospital Medical Center, Cincinnati (1) · Massachusetts General Hospital (1) · University of Michigan Rogel Cancer Center (1) · University of Washington (1) · Washington University School of Medicine (1) · West Virginia University (1)
United States (8)
Ann Stapleton, MD (1) · Arif R. Sarwari, MD, MSc, MBA (1) · Brian Turpin, D.O. (1) · Carlos Rodriguez-Galindo, MD (1) · David A Khan, MD (1) · Jennie H. Kwon, DO, MSCI (1) · Joy J. Juskowich, MD (1) · Kimberly G Blumenthal, MD, MSc (1) · Rajen Mody, MD (1) · Wayne Furman, M.D. (1)
U01AI184071 (1)